Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SSY GroupLJUIF 86 EV-to-OCF is 16.00 as of Sep. 11, 2026, which is 27% below its 10-year median of 21.80. GuruFocus rates LJUIF with a GF Score™ of 86/100 and a GF Value™ of $0.47. The stock has 7 warning signs investors should review. Among 1,006 Drug Manufacturers companies, SSY Group ranks worse than 64.21% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, SSY Group's Enterprise Value is $1,302.9 Mil.
SSY Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $81.4 Mil. Therefore, SSY Group's EV-to-OCF for today is 16.00.
The historical rank and industry rank for SSY Group's EV-to-OCF or its related term are showing as below:
LJUIF'
s EV-to-OCF Range Over the Past 10 Years
Min: 11.74 Med: 21.8 Max: 51.08
Current: 16.09
During the past 13 years, the highest EV-to-OCF of SSY Group was 51.08. The lowest was 11.74. And the median was 21.80.
LJUIF's EV-to-OCF is ranked worse than 64.21% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 10.305
vs LJUIF: 16.09
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SSY Group's share price for today is $0.40255.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SSY Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.020.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SSY Group EV-to-OCF Related Terms
SSY Group EV-to-OCF Historical Data
* Premium members only.
The historical data trend for SSY Group's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SSY Group EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SSY Group's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where SSY Group's EV-to-OCF falls into.
SSY Group's current Enterprise Value is $1,302.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SSY Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $81.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SSY Group (LJUIF) has a EV-to-OCF of 16.00 as of Sep. 11, 2026. This is 27% below median its historical median of 21.80. Over the past decade, SSY Group's EV-to-OCF has ranged from 11.74 to 51.08. According to the industry distribution chart, SSY Group ranks #646 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 64.2%.
Is SSY Group's EV-to-OCF too high?
SSY Group's current EV-to-OCF of 16.00 is 27% below median its 10-year median of 21.80. Over the past 10 years, this metric has ranged from a low of 11.74 to a high of 51.08. The Drug Manufacturers industry median EV-to-OCF is 10.31. SSY Group's value of 16.00 is 55.3% above this industry median. Based on the distribution chart, SSY Group ranks #646 out of 1006 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, SSY Group has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does SSY Group's EV-to-OCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, SSY Group ranks #646 out of 1006 companies for EV-to-OCF. This places SSY Group in the lower half of its industry. The industry median EV-to-OCF is 10.31. SSY Group's value of 16.00 is 55.3% above this benchmark. Historically, SSY Group's own EV-to-OCF has ranged from 11.74 to 51.08 over the past decade. While the company's 10-year median is 21.80 vs. the industry median of 10.31, SSY Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.31, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SSY Group's current EV-to-OCF of 16.00 is 55.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SSY Group's current EV-to-OCF is 16.00, which is 27% below median its own 10-year median of 21.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SSY Group stock overvalued right now?
SSY Group (LJUIF) has a current EV-to-OCF of 16.00. The stock's GF Value™ is $0.47, compared to a current price of $0.40 — trading 14.4% below its estimated fair value. The current EV-to-OCF is 16.00, which is 27% below median its 10-year median of 21.80 and 55.3% above the Drug Manufacturers industry median of 10.31. SSY Group's overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For SSY Group (LJUIF), the current EV-to-OCF is 16.00 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SSY Group (LJUIF) Overvalued in 2026?
Based on GuruFocus' analysis, SSY Group stock appears to be undervalued.
The current stock price of $0.40 is trading 14.4% below its estimated GF Value™ of $0.47.
Key valuation signals for LJUIF:
EV-to-OCF: 16.00 (27% below median its 10-year median of 21.80)
GF Value™: $0.47 vs. price of $0.40 (14.4% below fair value)
Industry Position: 55.3% above the Drug Manufacturers median (#646 of 1006)
No single metric tells the full story. See the LJUIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSY Group Ltd is engaged in the research, development, manufacturing, and selling of a wide range of pharmaceutical products, which include finished medicines of mainly intravenous infusion solutions and ampoule injections to hospitals and distributors, bulk pharmaceuticals, and medical materials. The company has two reportable segments, including intravenous infusion solutions and other medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products. The company derives maximum revenue from PRC.
86GF Score
Get the complete analysis for LJUIF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LJUIF has been successfully added to your 
